HI-Bio

About:

Human Immunology Biosciences is a biotechnology company that focuses on developing therapies for immune-mediated diseases.

Website: https://hibio.com

Twitter/X: HIBiosciences

Top Investors: ARCH Venture Partners, Viking Global Investors, Alpha Wave Global, MorphoSys, Arkin Holdings

Description:

Human Immunology Biosciences is a biotechnology company that focuses on developing therapies for immune-mediated diseases. The company's lead product, felzartamab, is a fully human anti-CD38 monoclonal antibody that has been shown in clinical studies to deplete CD38+ cells that include plasma cells and natural killer, or NK, cells which may allow for applications that improve clinical outcomes in a broad range of immune-mediated diseases.